NCT05667818 - An Comparative Pharmacokinetic Study of Amlodipine Besylate Controlled-release Tablets,China in Normal, Healthy, Adult, Human Subjects Under Fasting Conditions | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 28, 2023

Primary Completion Date

February 28, 2023

Study Completion Date

March 10, 2023

Conditions

Hypertension

Interventions

DRUG

Amlodipine besylate tablets (trade name: Norfloxacin ®）

Specification: 5 mg Batch No.: FX3445 Content: 100.2% Expiry date: January 2027 Storage conditions: dark and sealed Manufacturer: Pfizer Inc. Provider: Overseas Pharmaceuticals, Ltd. Take one tablet once a day.

DRUG

Amlodipine besylate controlled-release tablets

Test preparation (T): amlodipine besylate controlled-release tablets Specification: 5 mg Batch No.: 22102501 Content: 100.9% Expiry date: October 24, 2024 Storage conditions: dark, sealed at room temperature. Manufacturer: Overseas Pharmaceuticals, Ltd. Provider: Overseas Pharmaceuticals, Ltd. Take one tablet once a day.

Trial Locations (1)

510280

Zhujiang Hospital of Southern Medical University, Guangdong